Primary Percutaneous Coronary Intervention in Acute ST-Elevation Myocardial Infarction: The Experience of "Evagelismos" General Hospital of Athens


  • Prodromos Anthopoulos
  • Ioannis Antonellis
  • Georgios Yfantis
  • Anastasios Salahas
  • Isidoros Gavaliatsis
  • Spyros Koulouris
  • George Andrikopoulos
  • Ioannis Alexanian
  • Efrosini Kambitsi
  • Konstantinos Mihas
  • Stylianos Tzeis
  • Kostas Triantafyllou
  • Antonis Sideris
  • Ilias Siorras
  • Fotios Kardaras
  • Antonios Tavernarakis
  • Antonis S. Manolis



primary PCI, acute myocardial infarction, acute coronary syndromes, coronary angioplasty, coronary stenting, thrombolysis


We report our experience from treating a large number of patients who presented to the Emergency Department of our Hospital with ST-elevation acute myocardial infarction (AMI) with primary percutaneous coronary intervention (PCI). Of the 196 patients who presented with ST elevation AMI over a period of 12 months, 100 (51%) patients underwent primary PCI. Clinical and angiographic data were collected and patients were followed up for 9 months. Technical details of the primary PCI, including use of balloon, use of thrombus aspiration catheter, stent implantation, use of drug eluting stents, and use of GP IIb/IIIa inhibitors were recorded and correlated to clinical and angiographic patient data. Our results are in keeping with those published by other groups performing primary PCI. We demonstrated the importance of time interval from onset of symptoms until PCI is started. We found that the use of GP IIb/IIIa inhibitors was beneficial and emphasized the predictive value of left ventricular ejection fraction >50% and the importance of achieving TIMI 3 flow in the AMI related artery at the end of the procedure.




Cardiology Update 2006